Skip to content

RLAY

Relay Therapeutics, Inc.

Stock

$18.96+0.47 (+2.54%)Close Oct 2, 2026

EBITDA, 2025
−$299M

EBITDA

EBITDA by fiscal year

PeriodEBITDAYoY
2025−$299M—
2024−$367M—
2023−$368M—
2022−$295M—
2021−$361M—
2020−$52M—
2019−$81M—